Stock of the Week – TG Therapeutics (TGTX)

TG Therapeutics (TGTX) is a commercial-stage biopharmaceutical firm that treats autoimmune diseases, cancers, and other B-cell diseases. The company has received approval from the FDA for Briumvi, which treats patients with relapsing forms of multiple sclerosis. The...

Stock of the Week – Viking Therapeutics (VKTX)

Our Stock of the Week is Viking Therapeutics (VKTX). Viking is racing to launch an obesity drug that competes against Lilly (LLY) and Novo Nordisk (NVO). Preliminary results for its VK2735 showed excellent results with substantial weight reduction and fewer side...

Stock of the Week – AvePoint Inc (AVPT)

Our Stock of the Week is AvePoint (AVPT). AvePoint Inc. is a Microsoft 365 data management solutions provider that offers a full suite of SaaS solutions to migrate, manage, and protect data. It sees itself as a leader in data management and data governance and has...

Stock of the Week – Humacyte (HUMA)

Our Stock of the Week is Humacyte (HUMA). I’ve been discussing this stock extensively for a while, but with an FDA decision due in about a month and good support on the chart, it looks like an opportune time to evaluate the name. HUMA has developed the Acellular...